Source link : https://newshealth.biz/health-news/first-in-class-antidepressant-effective-in-ank3-positive-trd/
Liafensine, a new triple reuptake inhibitor, is effective and well tolerated in carriers of the ANK3 gene with treatment-resistant depression, according to a phase 2b trial. Medscape Medical News Source link : https://www.medscape.com/viewarticle/first-class-antidepressant-effective-ank3-positive-trd-2025a1000oa6?src=rss Author : Publish date : 2025-09-15 06:55:00 Copyright for syndicated content belongs to the linked Source.
The post First-in-Class Antidepressant Effective in ANK3-Positive TRD first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-15 06:55:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8